Stock Taper 
KEY STATISTICS
COMPANY
LEADERSHIP
COMPENSATION 2026
ABOUT
PRICE TARGET
UPCOMING EARNINGS
ETFS HOLDING THIS STOCK
INSTITUTIONAL OWNERSHIP
PRICE
$2.59 ▲ UP 9.75% (+$0.23)About Apyx Medical Corporation
https://apyxmedical.com ↗Apyx Medical Corporation develops and sells advanced energy medical devices, including Helium Plasma Generators and Renuvion products, for cosmetic and surgical markets worldwide.
INDUSTRY
A PRODUCT APYX MEDICAL CORPORATION IS KNOWN FOR
The AYON Body Contouring System by Apyx Medical is an FDA-cleared, all-in-one platform integrating fat removal, tissue contraction with Renuvion helium plasma, and electrosurgical tools for comprehensive aesthetic body contouring.
Apyx Medical in 2025
Apyx Medical's Groundbreaking AYON System Launch and FDA Clearance Reshapes the Body Contouring Market in 2025
Apyx Medical received FDA 510(k) clearance for its innovative AYON Body Contouring System in May 2025 and initiated a full U.S. commercial launch at the end of the third quarter. The launch of this all-in-one platform was met with stronger-than-expected demand, driving a significant increase in the company's Surgical Aesthetics revenue and a subsequent positive revision of its full-year financial guidance.
Apyx Medical Pivots to Surgical Aesthetics with Full U.S. Commercial Launch of AYON™ Body Contouring System
Apyx Medical initiated the full U.S. commercial launch of its AYON Body Contouring System in September 2025, following FDA 510(k) clearance in May. This launch represents a major strategic pivot, shifting resources and focus from its OEM segment to the higher-growth surgical aesthetics market, with AYON positioned as the company's key future growth driver.
RATINGS SNAPSHOT
Overall rating: D+
MOST RECENT ANALYST GRADES
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 RCEL | $12.98 | COMPARE |
 PDEX | $61.19 | COMPARE |
 LUCD | $0.63 | COMPARE |
 VANI | $1.21 | COMPARE |
 SERA | $2.12 | COMPARE |
 RPID | $0.84 | COMPARE |
 ATOS | $2.42 | COMPARE |
 NSPR | $0.49 | COMPARE |